Syverson Strege & Co
Source: SEC Form 13F · as of Mar 2026Syverson Strege & Co holds 18 biotech & pharma companies tracked by BioSniper, totaling $10.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$10.7M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 6,539 | $1.6M |
| ABTABBOTT LABORATORIES | 14,155 | $1.5M |
| ABBVAbbVie Inc. | 6,486 | $1.4M |
| LLYELI LILLY & Co | 931 | $856K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,082 | $563K |
| MRKMerck & Co., Inc. | 4,618 | $556K |
| MCKMcKesson Corporation | 634 | $549K |
| GMOptec International, Inc. | 7,148 | $533K |
| GILDGILEAD SCIENCES, INC. | 3,208 | $447K |
| PMPhilip Morris International Inc | 2,545 | $421K |
| PFEPFIZER INC | 13,475 | $378K |
| BMYBRISTOL MYERS SQUIBB CO | 5,613 | $340K |
| CORCencora Inc. | 1,053 | $331K |
| CAHCardinal Health Inc. | 1,542 | $326K |
| NVSNovartis AG | 1,973 | $301K |
| AMGNAMGEN INC | 756 | $266K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 3,847 | $212K |
| VTRSViatris Inc | 13,011 | $176K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.